Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1972 2
1975 1
1978 1
1979 2
1980 2
1982 1
1984 2
1985 5
1986 1
1987 2
1991 2
1992 1
1993 7
1994 3
1995 1
1996 1
1997 1
1998 4
1999 8
2000 6
2001 6
2002 8
2003 6
2004 2
2005 5
2006 14
2007 9
2008 6
2009 5
2010 3
2011 14
2012 4
2013 9
2014 11
2015 8
2016 13
2017 7
2018 13
2019 3
2020 10
2021 9
2022 9
2023 15
2024 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

232 results

Results by year

Filters applied: . Clear all
Page 1
Drug-induced hyperkalemia.
Ben Salem C, Badreddine A, Fathallah N, Slim R, Hmouda H. Ben Salem C, et al. Among authors: slim r. Drug Saf. 2014 Sep;37(9):677-92. doi: 10.1007/s40264-014-0196-1. Drug Saf. 2014. PMID: 25047526 Review.
Drug-induced hyperuricaemia and gout.
Ben Salem C, Slim R, Fathallah N, Hmouda H. Ben Salem C, et al. Among authors: slim r. Rheumatology (Oxford). 2017 May 1;56(5):679-688. doi: 10.1093/rheumatology/kew293. Rheumatology (Oxford). 2017. PMID: 27498351 Review.
Drug-Induced Hyperglycaemia and Diabetes.
Fathallah N, Slim R, Larif S, Hmouda H, Ben Salem C. Fathallah N, et al. Among authors: slim r. Drug Saf. 2015 Dec;38(12):1153-68. doi: 10.1007/s40264-015-0339-z. Drug Saf. 2015. PMID: 26370106 Review.
A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies.
Skokos D, Waite JC, Haber L, Crawford A, Hermann A, Ullman E, Slim R, Godin S, Ajithdoss D, Ye X, Wang B, Wu Q, Ramos I, Pawashe A, Canova L, Vazzana K, Ram P, Herlihy E, Ahmed H, Oswald E, Golubov J, Poon P, Havel L, Chiu D, Lazo M, Provoncha K, Yu K, Kim J, Warsaw JJ, Stokes Oristian N, Siao CJ, Dudgeon D, Huang T, Potocky T, Martin J, MacDonald D, Oyejide A, Rafique A, Poueymirou W, Kirshner JR, Smith E, Olson W, Lin J, Thurston G, Sleeman MA, Murphy AJ, Yancopoulos GD. Skokos D, et al. Among authors: slim r. Sci Transl Med. 2020 Jan 8;12(525):eaaw7888. doi: 10.1126/scitranslmed.aaw7888. Sci Transl Med. 2020. PMID: 31915305
Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy.
Waite JC, Wang B, Haber L, Hermann A, Ullman E, Ye X, Dudgeon D, Slim R, Ajithdoss DK, Godin SJ, Ramos I, Wu Q, Oswald E, Poon P, Golubov J, Grote D, Stella J, Pawashe A, Finney J, Herlihy E, Ahmed H, Kamat V, Dorvilliers A, Navarro E, Xiao J, Kim J, Yang SN, Warsaw J, Lett C, Canova L, Schulenburg T, Foster R, Krueger P, Garnova E, Rafique A, Babb R, Chen G, Stokes Oristian N, Siao CJ, Daly C, Gurer C, Martin J, Macdonald L, MacDonald D, Poueymirou W, Smith E, Lowy I, Thurston G, Olson W, Lin JC, Sleeman MA, Yancopoulos GD, Murphy AJ, Skokos D. Waite JC, et al. Among authors: slim r. Sci Transl Med. 2020 Jun 24;12(549):eaba2325. doi: 10.1126/scitranslmed.aba2325. Sci Transl Med. 2020. PMID: 32581132
Perindopril/Indapamide-Induced Photosensitivity.
Ben Salem C, Sahnoun D, Zayani H, Slim R, Denguezli M. Ben Salem C, et al. Among authors: slim r. Hosp Pharm. 2024 Feb;59(1):5-6. doi: 10.1177/00185787231188919. Epub 2023 Jul 22. Hosp Pharm. 2024. PMID: 38223870 No abstract available.
Biliary coil migration.
Slim R, Khoueiry C, Yaghi C. Slim R, et al. Frontline Gastroenterol. 2022 Dec 6;14(5):442-443. doi: 10.1136/flgastro-2022-102357. eCollection 2023. Frontline Gastroenterol. 2022. PMID: 37581190 Free PMC article. No abstract available.
[Drug-induced vasculitis].
Fathallah N, Ouni B, Mokni S, Baccouche K, Atig A, Ghariani N, Azzabi A, Denguezli M, Slim R, Ben Salem C. Fathallah N, et al. Among authors: slim r. Therapie. 2019 Jun;74(3):347-354. doi: 10.1016/j.therap.2018.07.005. Epub 2018 Jul 24. Therapie. 2019. PMID: 30173896 French.
A Biparatopic Antibody-Drug Conjugate to Treat MET-Expressing Cancers, Including Those that Are Unresponsive to MET Pathway Blockade.
DaSilva JO, Yang K, Surriga O, Nittoli T, Kunz A, Franklin MC, Delfino FJ, Mao S, Zhao F, Giurleo JT, Kelly MP, Makonnen S, Hickey C, Krueger P, Foster R, Chen Z, Retter MW, Slim R, Young TM, Olson WC, Thurston G, Daly C. DaSilva JO, et al. Among authors: slim r. Mol Cancer Ther. 2021 Oct;20(10):1966-1976. doi: 10.1158/1535-7163.MCT-21-0009. Epub 2021 Jul 26. Mol Cancer Ther. 2021. PMID: 34315762 Free PMC article.
232 results